# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-22-000117
Filing Date
2022-08-09
Accepted
2022-08-09 16:13:25
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20220630.htm iXBRL | 10-Q | 1741429
2 | EX-10.2 | exhibit_102xligand-2022ind.htm | EX-10.2 | 145237
3 | EX-10.3 | exhibit_103xligand-formofs.htm | EX-10.3 | 77321
4 | EX-10.4 | exhibit104_ligand-formofrs.htm | EX-10.4 | 56461
5 | EX-10.5 | exhibit_105xligand-formofp.htm | EX-10.5 | 62601
6 | EX-31.1 | lgnd_63022exhibit311.htm | EX-31.1 | 15166
7 | EX-31.2 | lgnd_63022exhibit312.htm | EX-31.2 | 15399
8 | EX-32.1 | lgnd_63022exhibit321.htm | EX-32.1 | 11345
14 |  | lgnd-20220630_g1.jpg | GRAPHIC | 51754
| Complete submission text file | 0000886163-22-000117.txt |  | 8879363

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20220630.xsd | EX-101.SCH | 45598
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20220630_cal.xml | EX-101.CAL | 92277
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20220630_def.xml | EX-101.DEF | 256602
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20220630_lab.xml | EX-101.LAB | 651603
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20220630_pre.xml | EX-101.PRE | 419141
61 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20220630_htm.xml | XML | 1644429

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 221148456
SIC: 2834 Pharmaceutical Preparations